Welcome Message

Dear Colleagues, Researchers, and Esteemed Experts,

It is with great excitement and honor that we welcome you to the 4th Experts Meeting on Cancer Medicine, Radiology & Treatment, taking place on October 22-23, 2025, in the captivating city of Paris, France. This pivotal event brings together the brightest minds and passionate professionals from around the globe to foster collaboration, innovation, and excellence in the fight against cancer.

The theme for this year’s meeting, “Advancing Precision, Technology, and Care in Cancer Treatment,” reflects our commitment to exploring cutting-edge research, breakthroughs in diagnostic radiology, and transformative therapies that shape the future of oncology.

Over the course of two days, attendees will have the opportunity to:

• Engage in thought-provoking discussions led by distinguished keynote speakers.
• Gain insights into groundbreaking clinicaltrials, radiological advancements, and emerging cancer treatments.
• Network with professionals dedicated to enhancing patient outcomes and elevating standards of care.

Paris, a city renowned for its history, art, and innovation, offers the perfect backdrop for this meeting. Beyond the conference, we encourage you to immerse yourself in its culture, from iconic landmarks to its vibrant culinary scene.

We are truly honored to have you join us in this endeavor to advance cancer medicine and radiology. Together, we aim to inspire progress and build a future of hope and resilience for patients worldwide.

Let us make this conference a memorable and impactful experience. Welcome to Paris, and welcome to the 4th Experts Meeting on Cancer Medicine, Radiology & Treatment!

Warm regards,
Cancer Meeting Summit 2025

Sessions&Tracks

Cancer Cell Biology & Genetics
Cancer cell biology focuses on the structure and function of cancer cells. Cancer is characterized by abnormal cell growth, with the potential to invade or spread to other parts of the body, distinguishing it from benign tumors. Normal cell division aids growth and repair, but cancer cells persistently divide, ignoring the body's signals to stop. This unregulated growth often leads to metastasis, where cancer spreads to other parts of the body. Genetic mutations causing DNA damage and genomic instability are primary drivers of cancer formation.

Cancer & Stem Cell Therapy
Cancer stem cells (CSCs) exhibit traits similar to normal stem cells, including self-renewal and differentiation. CSCs are tumorigenic and may resist conventional chemotherapeutic agents. Their unique properties, such as enhanced DNA repair and resistance mechanisms, make them difficult to eliminate. Developing targeted therapies for CSCs offers hope for improving survival rates and quality of life for patients with metastatic cancer.

Cancer Biomarkers
Biomarkers are molecules that indicate the presence of cancer, either through tumor-derived substances or bodily responses to tumors. Biomarkers assist in cancer diagnosis, prognosis, and monitoring. Examples include AFP (liver cancer), BCR-ABL (chronic myeloid leukemia), and BRCA1/BRCA2 (breast/ovarian cancer). Non-invasive biomarker testing using blood or bodily fluids holds promise for early detection.

Cancer Screening & Chemotherapy
Screening aims to detect cancer early, improving treatment outcomes. Reliable methods such as blood tests, imaging, and DNA analysis are essential. Chemotherapy, a cornerstone of cancer treatment, involves anti-cancer drugs to eliminate or slow tumor growth. It can be curative or palliative, often used in combination with other therapies to enhance effectiveness.

Cancer Causes and Risk Factors
Cancer arises from genetic mutations leading to uncontrolled cell growth. Environmental and lifestyle factors, such as smoking, poor diet, obesity, infections, and radiation exposure, play significant roles. Hormonal imbalances, chronic inflammation, and viral infections are additional contributors. Awareness of these factors is critical for prevention and early intervention.

Cancer Early Detection, Diagnosis, and Prognosis
Early detection of cancer through symptoms, screening, and diagnostic tests like imaging and biopsies is crucial for better outcomes. Prognosis refers to predicting disease progression, which guides treatment decisions and provides insight into expected quality of life.

Cancer Awareness and Survival
Raising awareness about cancer symptoms and risk factors can significantly improve survival rates. Socioeconomic disparities often affect access to quality care. Campaigns and educational programs must focus on underserved populations to enhance early diagnosis and treatment adherence.
Cancer Prevention & Research
Preventative measures such as avoiding tobacco, maintaining a healthy weight, and staying physically active can reduce cancer risk. Advances in cancer research focus on understanding its causes, developing treatments, and exploring preventive vaccines.

Tumor Virology, Immunology & Cellular Pathology
Certain viruses, such as HPV and Hepatitis B, are associated with cancer development. Cancer immunology studies the immune system's role in combating tumors, paving the way for immunotherapies that activate the body’s defenses to target cancer cells.

Cancer Biopsy
Biopsies are essential for diagnosing cancer, involving the examination of tissue samples under a microscope. They provide critical insights into tumor type, stage, and genetic profile, guiding personalized treatment approaches.

Surgical and Clinical Oncology
Surgical oncology involves removing tumors through advanced techniques like laparoscopic and robotic surgery, ensuring precision and minimal recovery time. Clinical oncologists use chemotherapy, radiotherapy, and systemic treatments to manage cancer, working in multidisciplinary teams to tailor care.

Gynecological Cancers
This field focuses on cancers affecting the female reproductive system, such as ovarian, uterine, and cervical cancers. Treatment often combines surgery, chemotherapy, and hormonal therapy, with efforts to improve survival and quality of life.

Neurological Cancers & Brain Tumors
Brain and spinal cord tumors, including gliomas and astrocytomas, present unique challenges due to their location. Treatment may involve surgery, radiotherapy, or chemotherapy, with ongoing research into more effective therapies.

Neonatal & Pediatric Oncology
Childhood cancers, such as leukemia and brain tumors, differ biologically from adult cancers. Research focuses on improving survival rates through specialized treatments tailored to young patients.

Oncology Nursing Care
Oncology nursing addresses the needs of cancer patients, from prevention and screening to treatment and symptom management. Nurses play a pivotal role in educating patients and their families, ensuring holistic care.

Cancer Vaccines
Cancer vaccines aim to prevent or treat cancer by stimulating the immune system. Preventive vaccines, such as those for HPV, have successfully reduced the incidence of related cancers. Therapeutic vaccines are an emerging area of research.

Organ-Specific Cancers
Organ-specific cancer research explores targeted approaches to treat cancers in particular organs, such as the liver, lungs, and prostate. Personalized therapies improve precision and effectiveness.

Oncolytic Virus and Cancer
Oncolytic viruses selectively infect and destroy cancer cells while sparing normal tissues. They represent a promising avenue in cancer immunotherapy, with ongoing research to enhance their efficacy.

DNA Damage, Mutation, and Cancer
DNA damage and mutations disrupt normal cellular function, leading to cancer. Cells have mechanisms to repair damage, but when these fail, mutations accumulate, promoting tumor growth.

Oncology Radiology & Nanotechnology
Radiotherapy and nanotechnology revolutionize cancer treatment. Radiation therapy targets tumors with precision, while nanotechnology improves drug delivery, minimizes side effects, and enhances treatment outcomes.

Target Audience

To focus specifically on cancer-related professionals and stakeholders, consider the following groups:

Medical Professionals Specializing in Cancer Care

• Oncologists (Medical, Surgical, and Radiation Oncology)
• Hematologists working on blood cancers
• Gynecologic Oncologists
• Pediatric Oncologists
• Urologists and Proctologists specializing in cancer care
•  Oncology Nurses and Nurse Practitioners

Cancer Researchers and Scientists

• Experts in Cancer Biology and Genomics
• Researchers in Molecular Oncology and Immunotherapy
• Specialists in Tumor Microenvironment Studies
• Innovators in Cancer Stem Cell Research
• Translational Researchers bridging lab work and clinical applications

Hospitals and Cancer Centers

• Multispecialty and Cancer-Specialized Hospitals
• Comprehensive Cancer Research and Treatment Centers
• Palliative Care Units

Pharmaceutical and Biotech Industry Professionals

• Oncology Drug Developers
• Experts in Immuno-Oncology Therapeutics
• Developers of Targeted Therapies and Chemotherapeutics
• Industry Leaders in Cancer Vaccines

Radiologists and Imaging Experts

• Oncologic Radiologists specializing in MRI, CT, PET, and Ultrasound Imaging
• Developers of Advanced Diagnostic Imaging Tools
• Researchers in Radiomics and Image-Guided Therapy

Pathologists and Diagnostic Experts

• Specialists in Cancer Pathology and Histopathology
• Cytologists focusing on early cancer detection
• Developers of Biomarker-Based Diagnostic Tools

Clinical Trials and Translational Research Specialists

• Clinical Trial Coordinators in Oncology
• Researchers in Phase I–IV Oncology Trials
• Translational Oncology Experts

Public Health and Cancer Prevention Experts

• Epidemiologists studying cancer trends and prevention
• Specialists in Cancer Screening Programs
• Advocates for Tobacco Control and Environmental Risk Reduction

Patient Support and Advocacy Groups

• Leaders of Cancer Survivor Networks
• Patient Advocates for Access to Treatments
• Organizations promoting patient education and awareness

Innovators in Technology and Cancer Care

• Developers of Artificial Intelligence in Oncology
• Innovators in Wearable Devices for Cancer Monitoring
• Specialists in Robotics for Oncologic Surgery

Psycho-Oncology and Supportive Care Providers

• Mental Health Experts supporting cancer patients
• Specialists in Cancer Rehabilitation and Quality of Life Research
• Professionals in Nutrition and Exercise for Oncology

Policy Makers and Health Authorities

• Government Agencies working on Cancer Control Programs
• Organizations funding Cancer Research Initiatives

This specialized focus ensures the conference brings together key players dedicated to cancer research, treatment, and care for meaningful collaboration.

Market Analysis

The cancer medicine, radiology, and treatment market is a rapidly growing segment within the global healthcare industry, driven by the increasing prevalence of cancer, advancements in technology, and rising investments in research and development. Here's an overview of the market trends, growth drivers, and challenges:

Market Size and Growth

• Market Value: The global cancer therapeutics market is projected to exceed $250 billion by 2030, growing at a compound annual growth rate (CAGR) of approximately 8–10% from 2023 to 2030.

• Radiology Segment: The radiology market, including imaging techniques such as CT, MRI, and PET scans, is expected to grow at a CAGR of 7%, driven by increasing adoption of AI and machine learning for diagnostics.

Key Regions:

• North America: Largest market due to advanced healthcare infrastructure and high R&D investments.

• Asia-Pacific: Fastest-growing region, with countries like China and India witnessing significant developments due to increasing healthcare access and awareness.

Market Drivers

Rising Cancer Prevalence: With over 19 million new cancer cases diagnosed annually (as of 2023), the demand for innovative treatments is surging.

Technological Advancements:

• Development of immunotherapies (e.g., CAR T-cell therapies).
• Use of personalized medicine and genomic profiling.
• Integration of AI in radiology for enhanced imaging and diagnostics.
• Government Initiatives and Funding:
• Increased funding for cancer research.
• Awareness programs promoting early detection and screening.
• Aging Population: The rising geriatric population is contributing to a higher incidence of cancer and demand for treatments.

Key Market Segments

Cancer Medicines:

• Chemotherapy drugs.
• Targeted therapy drugs.
• Hormone therapies.
• Immunotherapies.

Radiology:

• Diagnostic imaging (e.g., MRI, CT scans).
• Interventional radiology.
• Radiation therapy equipment.

Treatment Modalities:

• Surgical interventions.
• Radiotherapy.
• Systemic therapies.

Challenges

• High Costs: Cancer treatments, especially novel therapies, remain expensive, limiting accessibility in low-income regions.

• Regulatory Hurdles: Strict regulatory processes can delay the approval of innovative drugs and devices.

• Side Effects and Resistance: Many therapies, like chemotherapy, have severe side effects, and resistance to treatment is a growing concern.

Trends and Innovations

• Liquid Biopsies: Emerging as a non-invasive diagnostic tool for early cancer detection.
• Proton Therapy: A precise form of radiation therapy that minimizes damage to healthy tissues.
• AI-Driven Diagnostics: Improving accuracy and efficiency in cancer imaging.
• Nanomedicine: Offering targeted drug delivery systems to enhance therapeutic outcomes.

Major Players

• Pharmaceutical Companies: Roche, Merck & Co., Bristol-Myers Squibb, and Pfizer.
• Radiology Equipment Manufacturers: Siemens Healthineers, GE Healthcare, and Philips.
• Emerging Biotechs: Innovating in niche areas like gene therapy and novel drug delivery.

Future Outlook

• Integration of precision medicine and AI in treatment strategies will transform the market.
• Efforts to improve affordability and access to cancer care, especially in developing countries, will further drive growth.
• Continued collaboration between public and private sectors will be key to addressing global cancer challenges.